Paradoxically, MAOB exhibits tumor-suppressive effects in endometrial cancer (40) and hepatocellular carcinoma (41), while its loss promotes renal (34, 42) and bladder cancer progression (43–45). This evidence concerns the gene MAOB and hepatocellular carcinoma.